Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Plecanatide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 752,611Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Salix Will Present XIFAXAN(R, TRULANCE and RELISTOR Data at Scientific Meeting
    Salix Will Present XIFAXAN(R, TRULANCE and RELISTOR Data at Scientific Meeting

    24 Oct 2022

    // ACCESSWIRE

    https://www.accesswire.com/721607/Salix-Will-Present-XIFAXANR-Rifaximin-TRULANCER-Plecanatide-and-RELISTORR-Methylnaltrexone-Bromide-Data-at-The-American-College-of-GastroenterologyR-2022-Annual-Scientific-Meeting

    ACCESSWIRE
    24 Oct 2022
    Share Share
    Salix To Highlight New Data Across Its Portfolio Products At Digestive Disease
    Salix To Highlight New Data Across Its Portfolio Products At Digestive Disease

    30 Apr 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/salix-to-highlight-new-data-across-its-portfolio-of-products-at-digestive-disease-week-2020-virtual-meeting-301049876.html

    PRNEWSWIRE
    30 Apr 2020
    Share Share
    Cipher Pharma's Receives Health Canada Approval For Trulance® (Plecanatide)
    Cipher Pharma's Receives Health Canada Approval For Trulance® (Plecanatide)

    19 Oct 2019

    // BIOSPACE

    https://www.biospace.com/article/releases/cipher-pharmaceuticals-receives-health-canada-approval-for-trulance-and-174-plecanatide-/?s=95

    BIOSPACE
    19 Oct 2019
    Share Share
    Sun BioPharma founder Michael Cullen steps up; SemaThera settles on CEO
    Sun BioPharma founder Michael Cullen steps up; SemaThera settles on CEO

    02 Nov 2018

    // Amber Tong ENDPTS

    https://endpts.com/sun-biopharma-founder-michael-cullen-steps-up-semathera-settles-on-permanent-ceo-oncosec-nabs-kellie-malloy-foerter-from-syneos/

    Amber Tong ENDPTS
    02 Nov 2018
    Share Share
    Synergy Pharmaceuticals Provides Business Update
    Synergy Pharmaceuticals Provides Business Update

    28 Oct 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20181025006041/en

    BUSINESSWIRE
    28 Oct 2018
    Share Share
    Constipation drug maker Synergy looks to renegotiate bloated loan agreement — shares tumble
    Constipation drug maker Synergy looks to renegotiate bloated loan agreement — shares tumble

    26 Oct 2018

    // John Carroll ENDPTS

    https://endpts.com/constipation-drug-maker-synergy-looks-to-renegotiate-bloated-loan-agreement-shares-tumble/

    John Carroll ENDPTS
    26 Oct 2018
    Share Share